1. Researchers call out Gilead over diversity of remdesivir trials — Bristol-Myers commits $300M to combat racial disparities — Goldman predicts at least one coronavirus vaccine approval before the end of 2020 — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Abbott Point of Care

Discussion in 'Abbott' started by anonymous, Apr 30, 2020 at 4:13 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    I am considering a U.S. sales job at POC. What are the issues with the product? How is leadership?